End-of-life care in pediatric and congenital heart disease

Adrienne Kovacs, Anne I. Dipchand, Matthias Greutmann, Daniel Tobler

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Marked advances in the diagnosis and treatment of congenital heart disease (CHD) and other pediatric-onset cardiac conditions have significantly increased survival, such that the majority of patients are now expected to reach adulthood. However, childhood mortality will not completely disappear and there continues to be a subgroup of patients with complex heart disease who will die in childhood. In addition, CHD, particularly of moderate to great complexity, remains a chronic medical condition associated with premature mortality in adulthood. Patients with congenital and pediatric heart disease have end-of-life (EOL) care considerations unique from those of adult patients dying of acquired heart disease. Though EOL considerations certainly vary between neonates, children and adolescents, and adults, an emphasis on communication and interdisciplinary care is recommended in order to improve advance care planning and EOL care for this deserving group of patients.

Original languageEnglish (US)
Title of host publicationEnd-of-Life Care in Cardiovascular Disease
PublisherSpringer-Verlag London Ltd
Pages137-154
Number of pages18
ISBN (Electronic)9781447165217
ISBN (Print)9781447165200
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Terminal Care
heart disease
Heart Diseases
Pediatrics
adulthood
Interdisciplinary Communication
mortality
Advance Care Planning
childhood
Premature Mortality
dying
Newborn Infant
adolescent
planning
Survival
Mortality
communication
Group

Keywords

  • Advance care planning
  • Congenital heart disease
  • Death and dying
  • End of life
  • Palliative care
  • Pediatric heart disease

ASJC Scopus subject areas

  • Medicine(all)
  • Social Sciences(all)
  • Psychology(all)

Cite this

Kovacs, A., Dipchand, A. I., Greutmann, M., & Tobler, D. (2015). End-of-life care in pediatric and congenital heart disease. In End-of-Life Care in Cardiovascular Disease (pp. 137-154). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-6521-7_9

End-of-life care in pediatric and congenital heart disease. / Kovacs, Adrienne; Dipchand, Anne I.; Greutmann, Matthias; Tobler, Daniel.

End-of-Life Care in Cardiovascular Disease. Springer-Verlag London Ltd, 2015. p. 137-154.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kovacs, A, Dipchand, AI, Greutmann, M & Tobler, D 2015, End-of-life care in pediatric and congenital heart disease. in End-of-Life Care in Cardiovascular Disease. Springer-Verlag London Ltd, pp. 137-154. https://doi.org/10.1007/978-1-4471-6521-7_9
Kovacs A, Dipchand AI, Greutmann M, Tobler D. End-of-life care in pediatric and congenital heart disease. In End-of-Life Care in Cardiovascular Disease. Springer-Verlag London Ltd. 2015. p. 137-154 https://doi.org/10.1007/978-1-4471-6521-7_9
Kovacs, Adrienne ; Dipchand, Anne I. ; Greutmann, Matthias ; Tobler, Daniel. / End-of-life care in pediatric and congenital heart disease. End-of-Life Care in Cardiovascular Disease. Springer-Verlag London Ltd, 2015. pp. 137-154
@inbook{2e267437afc2440396e3a46934a395f5,
title = "End-of-life care in pediatric and congenital heart disease",
abstract = "Marked advances in the diagnosis and treatment of congenital heart disease (CHD) and other pediatric-onset cardiac conditions have significantly increased survival, such that the majority of patients are now expected to reach adulthood. However, childhood mortality will not completely disappear and there continues to be a subgroup of patients with complex heart disease who will die in childhood. In addition, CHD, particularly of moderate to great complexity, remains a chronic medical condition associated with premature mortality in adulthood. Patients with congenital and pediatric heart disease have end-of-life (EOL) care considerations unique from those of adult patients dying of acquired heart disease. Though EOL considerations certainly vary between neonates, children and adolescents, and adults, an emphasis on communication and interdisciplinary care is recommended in order to improve advance care planning and EOL care for this deserving group of patients.",
keywords = "Advance care planning, Congenital heart disease, Death and dying, End of life, Palliative care, Pediatric heart disease",
author = "Adrienne Kovacs and Dipchand, {Anne I.} and Matthias Greutmann and Daniel Tobler",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-6521-7_9",
language = "English (US)",
isbn = "9781447165200",
pages = "137--154",
booktitle = "End-of-Life Care in Cardiovascular Disease",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - End-of-life care in pediatric and congenital heart disease

AU - Kovacs, Adrienne

AU - Dipchand, Anne I.

AU - Greutmann, Matthias

AU - Tobler, Daniel

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Marked advances in the diagnosis and treatment of congenital heart disease (CHD) and other pediatric-onset cardiac conditions have significantly increased survival, such that the majority of patients are now expected to reach adulthood. However, childhood mortality will not completely disappear and there continues to be a subgroup of patients with complex heart disease who will die in childhood. In addition, CHD, particularly of moderate to great complexity, remains a chronic medical condition associated with premature mortality in adulthood. Patients with congenital and pediatric heart disease have end-of-life (EOL) care considerations unique from those of adult patients dying of acquired heart disease. Though EOL considerations certainly vary between neonates, children and adolescents, and adults, an emphasis on communication and interdisciplinary care is recommended in order to improve advance care planning and EOL care for this deserving group of patients.

AB - Marked advances in the diagnosis and treatment of congenital heart disease (CHD) and other pediatric-onset cardiac conditions have significantly increased survival, such that the majority of patients are now expected to reach adulthood. However, childhood mortality will not completely disappear and there continues to be a subgroup of patients with complex heart disease who will die in childhood. In addition, CHD, particularly of moderate to great complexity, remains a chronic medical condition associated with premature mortality in adulthood. Patients with congenital and pediatric heart disease have end-of-life (EOL) care considerations unique from those of adult patients dying of acquired heart disease. Though EOL considerations certainly vary between neonates, children and adolescents, and adults, an emphasis on communication and interdisciplinary care is recommended in order to improve advance care planning and EOL care for this deserving group of patients.

KW - Advance care planning

KW - Congenital heart disease

KW - Death and dying

KW - End of life

KW - Palliative care

KW - Pediatric heart disease

UR - http://www.scopus.com/inward/record.url?scp=84948097833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948097833&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-6521-7_9

DO - 10.1007/978-1-4471-6521-7_9

M3 - Chapter

AN - SCOPUS:84948097833

SN - 9781447165200

SP - 137

EP - 154

BT - End-of-Life Care in Cardiovascular Disease

PB - Springer-Verlag London Ltd

ER -